Results 151 to 160 of about 18,906 (239)
ABSTRACT Background Oral potentially malignant disorders (OPMDs) represent a diverse group of mucosal disorders with varying risks of progression to oral cancer. Objective This updated systematic review (SR) and meta‐analysis (MA) estimated the global prevalence of histopathologically confirmed OPMDs, excluding oral lichen planus and lichenoid lesions.
Nicole Lonni +6 more
wiley +1 more source
Dupilumab as a novel therapy for eruptive lichen planus in an Asian patient with metabolic syndrome. [PDF]
Tay RC, Tan E, Tan SH.
europepmc +1 more source
Off-Label Use of Upadacitinib for Treatment of Lichen Planus: A Narrative Review. [PDF]
Gregory M, Esfandiari N, Daveluy S.
europepmc +1 more source
Aggressive squamous cell carcinomas arising from mucosal lichen planus: A report of three cases
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page e1129-e1132, August 2026.
Neda Cramer +5 more
wiley +1 more source
Oxidative stress and metabolic dysfunction in oral lichen planus pathogenesis. [PDF]
Song HJ, Kang KH, Byun JS, Kim DY.
europepmc +1 more source
Aggressive Plattenepithelkarzinome auf dem Boden eines Lichen ruber mucosae: Bericht über drei Fälle
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page 1129-1133, August 2026.
Neda Cramer +5 more
wiley +1 more source
Therapeutic Outcomes of Janus Kinase Inhibitors in Refractory Nail Lichen Planus: A Systematic Review. [PDF]
Aqeel S +9 more
europepmc +1 more source
Refractory oral and cutaneous lichen planus successfully treated with upadacitinib. [PDF]
Riekhof I, Reed A, Pham A.
europepmc +1 more source
Oral Lichen Planus and Systemic Diseases. [PDF]
Warnakulasuriya S +2 more
europepmc +1 more source

